Biomarkers for the early detection of acute kidney injury

Current Opinion in Pediatrics

Volumn 23, Issue 2, 2011, Pages 194-200

  Devarajan, Prasad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

acute kidney injury; acute renal failure; biomarker; interleukin 18; kidney injury molecule 1; liver type fatty acid binding protein; neutrophil gelatinase associated lipocalin

Indexed keywords

BIOLOGICAL MARKER; CREATININE; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LIVER TYPE FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RANDOMIZATION; REVIEW; STRESS;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CHILD; EARLY DIAGNOSIS; FATTY ACID-BINDING PROTEINS; HUMANS; INTERLEUKIN-18; LIPOCALINS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 79954426215     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328343f4dd     Document Type: Review

References (99)

1. Murray PT, Devarajan P, Levey AS, et al. A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol 2008; 3:864-868.
2. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17:1503-1520. (Pubitemid 43841396)
3. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17:127-132. (Pubitemid 351253035)
4. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010; 15:419-428.
5. Devarajan P. Neutrophil gelatinase-associated lipocalin - an emerging troponin for kidney injury. Nephrol Dial Transplant 2008; 23:3737-3743.
6. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med 2008; 36 (4 Suppl.):159-165.
7. Schneider J, Khemani R, Grushkin C, et al. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med 2010; 38:933-939. This is the largest published pediatric AKI epidemiology study to date.
8. Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71:1028-1035. (Pubitemid 46741996)
9. Goldstein SL, Devarajan P. Acute kidney injury leads to pediatric patient mortality. Nat Rev Nephrol 2010; 6:393-394.
10. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2008; 23:2151-2157.
11. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007; 156:203-212.
12. Devarajan P. Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 2007; 27:637-651. (Pubitemid 350180173)
13. Devarajan P. Proteomics for the investigation of acute kidney injury. Contrib Nephrol 2008; 160:1-16.
14. Devarajan P, Parikh C, Barasch J. Case 31-2007: a man with abdominal pain and elevated creatinine. N Engl J Med 2008; 358:312.
15. Devarajan P. NGAL in acute kidney injury: from serendipity to utility. Am J Kidney Dis 2008; 52:395-399.
16. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia-reperfusion. Kidney Int 2003; 63:1714-1724. (Pubitemid 36513317)
17. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 2003; 4:2534-2543. (Pubitemid 37169339)
18. Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24:307-315. (Pubitemid 39070114)
19. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115:610-621. (Pubitemid 40322235)
20. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005; 365:1231-1238. (Pubitemid 40469655)
21. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70:199-203. (Pubitemid 44000139)
22. Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008; 73:465-472. (Pubitemid 351186293)
23. Dent CL, Ma Q, Dastrala S, et al. Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11:R127.
24. Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3:665-673.
25. Krawczeski CD, Woo JG, Wang Y, et al. Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr (in press). This is a large validation study that establishes the utility of NGAL as an early predictive biomarker of AKI and its adverse outcomes in children after cardiac surgery.
26. Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105:485-491. (Pubitemid 44310430)
27. Koyner J, Bennett M, Worcester E, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008; 74:1059-1069.
28. Wagener G, Gubitosa G, Wang S, et al. Urinary neutrophil-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 2008; 52:425-433.
29. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009; 37:553-560.
30. Haase M, Bellomo R, Devarajan P, et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg 2009; 88:124-130.
31. Haase-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009; 24:3349-3354.
32. Perry TE, Muehlschlegel JD, Liu KY, et al. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg 2010; 110:1541-1547.
33. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
34. McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010; 5:211-219.
35. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:1012-1024. This is a meta-analysis of all published studies on NGAL as a biomarker of AKI in a variety of clinical contexts.
36. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006; 21:856-863. (Pubitemid 43740956)
37. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6:1639-1645. (Pubitemid 43945804)
38. Hall IE, Yarlagadda SG, Coca SG, et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010; 21:189-197. This is a large multicenter study that highlights the role of NGAL and IL-18 as early predictive biomarkers of graft function after kidney transplantation.
39. Hollmen ME, Kyllönen LE, Inkinen KA, et al. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2010. [Epub ahead of print]
40. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007; 22:2089-2095. (Pubitemid 350090716)
41. Gaspari F, Cravedi P, Mandalà M, et al. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase- associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract 2010; 115:c154-c160.
42. Wasilewska A, Zoch-ZwierzW, Taranta-Janusz K, et al. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol 2010; 25:889-897.
43. Zappitelli M, Washburn KM, Arikan AA, et al. Urine NGAL is an early marker of acute kidney injury in critically ill children. Crit Care 2007; 11:R84.
44. Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008; 36:1297-1303. (Pubitemid 351482681)
45. Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 2009; 47:79-82.
46. Yang HN, Boo CS, Kim MG, et al. Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury. Am J Nephrol 2010; 31:501-509.
47. De Geus HR, Bakker J, Lesaffre EM, et al. Neutrophil gelatinase- associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2010. [Epub ahead of print]
48. Siew ED, Ware LB, Gebretsadik T, et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009; 20:1823-1832.
49. Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Int Care Med 2010; 36:444-451.
50. Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus nonseptic acute kidney injury in critical illness. Int Care Med 2010; 36:452-461.
51. Constantin J-M, Futier E, Perbet S, et al. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 2010; 25:176e1-176e6.
52. Niemann CU, Walia A, Waldman J, et al. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transplant 2009; 15:1852-1860.
53. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148:810-819. (Pubitemid 351786928)
54. Boldt J, Suttner S, Brosch C, et al. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg 2009; 109:1752-1762.
55. Haase M, Fielitz-Haase A, Bellomo R, et al. Sodium bicarbonate to prevent acute kidney injury after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009; 37:39-47.
56. Capuano F, Goracci M, Luciani R, et al. Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system. Interact Cardiovasc Thorac Surg 2009; 9:797-801.
57. Trachtman H, Christen E, Cnaan A, et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol 2006; 21:989-994. (Pubitemid 43885099)
58. Kumpers P, Hafer C, Lukasz A, et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010; 14:R9.
59. De Geus HR, Betjes MG, Bakker J. Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients. Intensive Care Med 2010. [Epub ahead of print]
60. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 2010; 4:265-280. This is a comprehensive review of AKI and the role of NGAL as a biomarker.
61. Grenier FC, Ali S, Syed H, et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem 2010; 43:615-620.
62. Mitsnefes M, Kathman T, Mishra J, et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007; 22:101-108. (Pubitemid 46138368)
63. Devarajan P. The promise of biomarkers for personalized renal cancer care. Kidney Int 2010; 77:755-757.
64. Goldstein SL, Devarajan P. Acute kidney injury in childhood: should we be worried about progression to CKD? Pediatr Nephrol 2010. [Epub ahead of print]
65. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis (in press).
66. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:337-344.
67. Meijer E, BoertienWE, Nauta FL, et al. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am J Kidney Dis 2010. [Epub ahead of print]
68. Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007; 123:227-234. (Pubitemid 46613869)
69. Brunner HI, Mueller M, Rutherford C, et al. Urinary NGAL as a biomarker of nephritis in childhood-onset SLE. Arthritis Rheum 2006; 54:2577-2584.
70. Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol 2008; 23:403-412.
71. Hinze CH, SuzukiM, Klein-Gitelman M, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009; 60:2772-2781.
72. Yilmaz A, Sevketoglu E, Gedikbasi A, et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol 2009; 24:2387-2392.
73. Ichimura T, Bonventre JC, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998; 273:4135-4142. (Pubitemid 28103282)
74. Vaidya VS, Ramirez V, Ichimura T, et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290:F517-F529. (Pubitemid 43725006)
75. Liangos O, Periyanayagam MC, Vaidya VS, et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J AmSoc Nephrol 2007; 18:904-912.
76. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008; 73:863-869. (Pubitemid 351398278)
77. Liangos O, Tighiouart H, Perianayagam MC, et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009; 14:423-431. This study examines multiple biomarkers in the setting of cardiac surgery.
78. Vaidya VS, Ozer JS, Dieterle F, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 2010; 28:478-485.
79. Vaidya VS, Ford GM, Waikar SS, et al. A rapid urine test for early detection of kidney injury. Kidney Int 2009; 76:108-114.
80. Van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212:209-217. (Pubitemid 46852099)
81. Van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007; 84:1625-1630.
82. Waanders F, Vaidya VS, van Goor H, et al. Effect of renin-angiotensin- aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2009; 53:16-25.
83. Noiri E, Doi K, Negishi K, et al. Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 2009; 296:F669-F679.
84. Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid - binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18:2894-2902. (Pubitemid 350058396)
85. Negishi K, Noiri E, Doi K, et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 2009; 174:1154-1159.
86. Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010; 77:708-714. This is a comprehensive study of L-FABP as a biomarker of AKI and its outcomes.
87. Doi K, Noiri E, Maeda-Mamiya R, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med 2010; 38:2037-2042.
88. Kamijo A, Sugaya T, Hikawa A, et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006; 284 (1-2):175-182. (Pubitemid 44404425)
89. Nakamura T, Sugaya T, Kawagoe Y, et al. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 2005; 28:2728-2732. (Pubitemid 43951167)
90. Melnikov VY, Ecder T, Fantuzzi G, et al. Impaired IL-18 processing protects caspase-1 deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107:1145-1152. (Pubitemid 32422911)
91. Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43:405-414. (Pubitemid 38298199)
92. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16:3046-3052. (Pubitemid 44743502)
93. Washburn KK, Zappitelli M, Arikan AA, et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 2008; 23:566-572. (Pubitemid 351767629)
94. Shapiro NI, Trzeciak S, Hollander JE, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009; 37:96-104.
95. Shapiro NI, Trzeciak S, Hollander JE, et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010; 56:52.e1-59.e1.
96. Heise D, Rentsch K, Braeuer A, et al. Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin C, and alpha(1)-microglobulin for early detection of acute renal injury after cardiac surgery. Eur J Cardiothorac Surg 2010. [Epub ahead of print]
97. Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010. [Epub ahead of print]
98. Devarajan P, Krawczeski CD, Nguyen MT, et al. Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children. Am J Kidney Dis 2010; 56:632-642.
99. Haase M, Devarajan P, Fielitz-Haase A, et al. The outcome of neutrophil gelatinase-associated lipocalin (NGAL)-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol (in press). This is the first demonstration of the concept of 'biomarker-positive creatinine-negative' subclinical AKI status, which establishes the role of NGAL as a biomarker of adverse outcomes independent of serum creatinine.